LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 94.68 | 17.25 | 1024 | 6239 | 0.1641 | 0.6169 | MN20160310_N02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 94.68 | 17.25 | 58 | 6239 | 0.0093 | 0.1534 | MN20160310_N02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 94.68 | 17.25 | 1187 | 6239 | 0.1903 | 0.6452 | MN20160310_N02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.06 | 17.25 | 3 | 143 | 0.0209 | -0.4361 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.06 | 17.25 | 365 | 143 | 2.5486 | 1.7171 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 3.06 | 17.25 | 709 | 143 | 4.9506 | 2.3770 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.03 | 17.25 | 4 | 273 | 0.0146 | -0.3070 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.03 | 17.25 | 526 | 273 | 1.9242 | 1.3569 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 5.03 | 17.25 | 856 | 273 | 3.1314 | 1.6632 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.01 | 17.25 | 4 | 389 | 0.0103 | -0.2775 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.01 | 17.25 | 638 | 389 | 1.6380 | 1.2320 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 7.01 | 17.25 | 928 | 389 | 2.3825 | 1.4259 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.98 | 17.25 | 3 | 445 | 0.0067 | -0.3114 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.98 | 17.25 | 718 | 445 | 1.6132 | 1.2147 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 8.98 | 17.25 | 970 | 445 | 2.1794 | 1.3615 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.95 | 17.25 | 5 | 471 | 0.0106 | -0.2286 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.95 | 17.25 | 749 | 471 | 1.5883 | 1.2036 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 10.95 | 17.25 | 1014 | 471 | 2.1503 | 1.3480 | MN20160310_N02 | J12 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.91 | 17.25 | 5 | 494 | 0.0101 | -0.2257 | MN20160310_N02 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 12.91 | 17.25 | 774 | 494 | 1.5641 | 1.1936 | MN20160310_N02 | E14 |